Coherus Oncology, Inc.
CHRS
$1.42
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -111.50M | -129.74M | -142.80M | -118.02M | -130.94M |
| Total Depreciation and Amortization | 2.74M | 2.91M | 3.05M | 3.63M | 4.82M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.55M | 17.14M | 40.19M | 51.29M | 48.49M |
| Change in Net Operating Assets | -16.73M | 17.81M | 56.01M | 3.87M | 78.13M |
| Cash from Operations | -123.94M | -91.88M | -43.56M | -59.23M | 500.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.41M | -87.55M | -85.26M | -17.58M | 10.07M |
| Cash from Investing | -39.41M | -87.55M | -85.26M | -17.58M | 10.07M |
| Total Debt Issued | -- | -- | 0.00 | -141.00K | 36.98M |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | -260.39M |
| Issuance of Common Stock | 61.71M | 8.06M | 241.00K | 241.00K | 874.00K |
| Repurchase of Common Stock | -115.00K | -267.00K | -277.00K | -284.00K | -2.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.00K | 27.00K | 5.00K | -16.00K | 36.40M |
| Cash from Financing | 61.67M | 7.82M | -31.00K | -200.00K | -188.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.68M | -171.61M | -128.84M | -77.02M | -177.55M |